Watermark
  Back to Search Results

BGB-A317-309

Completed

Tislelizumab Combined With Chemotherapy Versus Chemotherapy Alone in Recurrent or Metastatic Nasopharyngeal Cancer (NPC)

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-309

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT03924986

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20182534

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / 75 Years

Accepts Healthy Volunteers? No

Study Documents

Plain Language Summary Study Protocol Statistical Analysis Plan